GovTribe
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Help
Definitive Contract HHSO100201200008C
Award Date
9/28/12
Potential Completion Date
12/21/20
Potential Value
$34M
Overview
Buyer Personas
Industry Personas
Buyer Personas In this Market
5
Activity
11
Transactions
11
Subawards
Opportunity Stack
1
Similar Awards
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Plus Therapeutics, Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN13 - Health R&D Services; Health Care Services; Experimental Development
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Not listed
Description
Update #1
Posted 9/26/12, 12:00 AM
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
BARDA-CBRN-BAA-11-100-SOL-00009
Added: Feb 18, 2011 4:59 pm BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the teat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the PHEMCE Implementation Plan for CBRN Teats. The Implementation Plan is located on the ASPR website: http://www.phe.gov/about/amcg/ard/Pages/default.aspx.In addition, the Pandemic and All Hazard Preparedness Act (PAHPA) directs BARDA to promote (i) innovations in technologies that may assist countermeasure and product advanced research and development (ii) research on and development of research tools and other devices and technologies and (iii) research to promote strategic initiations. The PAHPA is also located on the ASPR website: http://www.phe.gov/about/amcg/ard/Pages/default.aspx.The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest as listed here and further described in Part I.Research Areas of Interest:1. Vaccines Development2. Antitoxins and Therapeutics3. Antimicrobials and Antivirals4. Radiological and Nuclear Agent Countermeasures5. Chemical Agent Countermeasures6. DiagnosticsBARDA anticipates that research and development activities awarded from this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates' countermeasures for CBRN teats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS).The Government intends to have a full & open competition for this requirement in the form of a BAA. This synopsis is not a BAA; a BAA is anticipated on March 4, 2011. The Government expects to make 1 or more awards, subject to the availability of funds, on or about September 16, 2011. Contact Information:Comments to this announcement, referencing synopsis BARDA-CBRN-BAA-11-100-SOL-00009 may be submitted to CBRN-BAA-11@hhs.govPre-proposal Conference:A pre-proposal conference will be held on March 23rd, 2011 from 2-4 pm at the following address:200 Independence Avenue S.W.Hubert H Humpey Building 7th floor Room 725AWashington, DC 20201Please note the following regarding the pre-proposal conference:1. Enter the Humpey Building at the Independence Avenue Street entrance.2. Arrive 30 minutes early to allow time to clear security. 3. Bring a state-issued form of identification.*4. The closest metro stop is Federal Center SW5. Attendance is limited to a maximum of two (2) people per company. Email the names of your attendees to CBRN-BAA-11@hhs.gov by Friday, March 11, 2011.6. Tape recorders and videos are prohibited.7. Presentation material from the conference will be posted on FedBizOpps in an amendment to the BAA following the pre-proposal conference* Be advised that in order to obtain security clearance, advanced notification must be provided by all attendees who are not United States citizens.Pre-proposal Conference #2: A second pre-proposal conference is anticipated on or about June 8, 2011 in San Diego, CA and will be announced in a subsequent FedBizOpps amendment to this BAA.Questions from industry regarding the Special Instruction B (announced in a subsequent FedBizOpps amendment) may be emailed to CBRN-BAA@hhs.gov no later than March 15, 2011. Submitted questions will be addressed during the March 23rd Pre-Proposal Conference.NOTE: For those unable to attend, you may choose to dial-in and still participate in the conference. Please notify us of your interest in this option and use the following dial-in information: 1-800-369-2101 Participant code # 45746.
BARDA-CBRN-BAA-11-100-SOL-00009
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 1/1
2/18/11, 4:59 PM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00010
CHANGE OF NAME FROM CYTORI THERAPEUTICS, INC. TO PLUS THERAPEUTICS, INC.
Funding Only Action
($819k)
12/21/20
P00009
CHANGE OF NAME FROM CYTORI THERAPEUTICS, INC. TO PLUS THERAPEUTICS, INC.
Other Administrative Action
$0
8/1/20
8
CYTORI - PROOF OF CONCEPT FOR USE OF THE CELUTION SYSTEM AS A MEDICAL COUNTERMEASURE FOR THERMAL BURN::
Exercise an Option
$13.4m
5/23/17
7
CYTORI - PROOF OF CONCEPT FOR USE OF THE CELUTION SYSTEM AS A MEDICAL COUNTERMEASURE FOR THERMAL BURN::
Other Administrative Action
$0
5/19/17
6
CYTORI - PROOF OF CONCEPT FOR USE OF THE CELUTION SYSTEM AS A MEDICAL COUNTERMEASURE FOR THERMAL BURN::
Other Administrative Action
$0
3/17/17